THIS ANNOUNCEMENT AND THE INFORMATION HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.
FOR IMMEDIATE RELEASE
16 July 2025
Assura plc
Publication of employee opinion letters
In accordance with Rule 25.9(b) of the City Code on Takeovers and Mergers opinion letters from the representative of the employees of Assura Plc ("Assura") produced in respect of i) the recommended offer for Assura made by Primary Health Properties PLC; and ii) the offer for Assura made by Sana Bidco Limited have been published and are available at https://www.assuraplc.com/investor-relations/shareholder-information/offer-from-php and https://www.assuraplc.com/investor-relations/shareholder-information/offer-from-kkr-and-stonepeak respectively.
- ENDS -
For more information, please contact:
|
Assura plc |
Tel: 0161 515 2043 |
| David Purcell, Investor Relations Director |
|
| FGS Global Gordon Simpson |
Tel: 0207 251 3801
|
Notes to Editors
Assura plc is the UK's leading diversified healthcare REIT. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served.
A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA* indices and has a secondary listing on the Johannesburg Stock Exchange. As at 31 March 2025, Assura's portfolio was valued at £3.1 billion and has a strong track record of growing financial returns and dividends for shareholders.
At Assura we BUILD for health and as the first FTSE 250 certified B Corp we are committed to keeping ESG at the heart of our strategy, creating Healthy Environments (E) and Healthy Communities (S) and maintaining a Healthy Business (G).
Further information is available at www.assuraplc.com
* EPRA is a registered trademark of the European Public Real Estate Association
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.